Pfizer

Follow

This company has no active jobs

0 Review

Rate This Company ( No reviews yet )

Work/Life Balance
Comp & Benefits
Senior Management
Culture & Value

Pfizer

(0)

Company Information

About Us

New ‘discreet’ Viagra Launched ending Embarrassment Of Blue Pill

The makers of Viagra are set to introduce a brand-new ‘discrete’ kind of the drug that will replace the renowned – and immediately recognisable – little blue tablet.

The unique diamond-shaped tablets might quickly be replaced by a pink, rectangle-shaped ‘wafer’ that dissolves on the tongue, indicating it does not require to be taken with water.

About half of men over 40 suffer erectile dysfunction in the UK and last year there was a record 4.57 million prescriptions for Viagra on the NHS.

The drug initially came to the market in the 1990s after being developed by the American pharmaceutical business Pfizer.

It was first established in the 1980s as a cardiovascular disease medication, but trial participants noticed it had an unusual negative effects – regular erections.

Now, Pfizer spin-off Viatris, which owns the Viagra name and brand name, has actually applied for a hallmark in the UK for the new kind of the drug, Viagra ODF.

Viatris has currently introduced the Viagra ODF in Canada and promoted it as being ‘thin and discreet’ which may be more suitable for lots of consumers.

The unique tablets – which can cause shame for some clients – has actually been reinvented and a brand-new dissolvable type might be available to Brits in the next five years. Stock image

‘Tablets are not constantly bearable to patients and also often the size of tablets might put clients off having them,’ Thorrun Govind, pharmacist and health specialist, informed The Telegraph.

She included: ‘Some men might still be discovering the concept of having Viagr embarrassing, however I would hope that males’s health and conversations about sexual health have actually carried on because Viagra was very first created.’

Ms Govind believes this new style is a ‘favorable step forward’.

The new dissolvable medication is believed to most likely come to the UK imminently.

Rebecca Anderson-Smith, partner and chartered trade mark lawyer at Mewburn Ellis, told the paper that the hallmark application is a ‘good indication’ it will be available within the next 5 years.

She discussed trade mark registrations can be cancelled if they are not used for a constant duration of 5 years or more after registration. As a result, it appears Viatris plans to release the item within the next few years.

However, giving a hallmark would not guarantee the ODF could be offered and it would need to be approved by the Medicines & Healthcare items Regulatory Agency first.

It’s expected to cost the exact same as the tablet variation and to be readily available in the same doses.

An overall of 4.57 million prescriptions for sildenafil, more frequently known by the brand name Viagra, and other types of impotency drugs sold under the trademark name Cialis and Levitra, were dished out by the health service in 2023

This follows dodgy Viagra was discovered to be Britain’s most significant fake drug after more than ₤ 6.2 million of phony blue tablet were taken by UK regulators in 2023.

More of the erectile dysfunction drug were found than knock-off versions of painkillers like morphine.

Health authorities stated online retailers flouting guidelines lagged the fake products with a lot of being imported from nations like India without a suitable licence.

Data, from UK regulator The Medicines and Healthcare items Regulatory Agency (MHRA), show 2.6 million doses of sildenafil, the generic name for the medication best understood as Viagra, were taken in 2015.

Another half-million dosages of tadalafil, another erectile dysfunction drug sold under the brand name Cialis worth ₤ 1.2 million were likewise taken.

While all medications carry possible adverse effects drugs from unreliable sources may either not work or bring additional ingredients or pollutants like heavy metals or other drugs that might be hazardous.